Cajal Neuroscience
About:
Cajal Neuroscience is a drug discovery company focused on neurodegenerative disease.
Website: https://cajalneuro.com
Twitter/X: CajalNeuro
Top Investors: Alexandria Venture Investments, Evotec, Bristol-Myers Squibb, Two Sigma Ventures, Lux Capital
Description:
Cajal Neuroscience is a biotechnology company integrating human genetics, functional genomics, and advanced microscopy to discover novel targets and therapeutics for neurodegeneration. The company combines a suite of state-of-the-art approaches and technologies, including integrative human genetics and multi-omics, high-throughput functional genomics, and advanced microscopy, to accelerate neurodegeneration target and drug discovery.
$96M
$10M to $50M
Seattle, Washington, United States
2020-01-01
info(AT)cajalneuro.com
Alex Vaughan, Andrew Dervan, Charles Zuker, Huda Zoghbi, Ian Peikon, Robert M. Hershberg
51-100
2022-11-29
Private
© 2025 bioDAO.ai